Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis
Authors:
- Wen ZhangWZWen Zhang
- Bo GuiBGBo Gui
- Alzheimer'S Disease Neuroimaging InitiativeAIAlzheimer'S Disease Neuroimaging Initiative
Open Access
- 12 June 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (7) , 4583-4593
Abstract
BACKGROUND: Mild cognitive impairment (MCI) heightens Alzheimer's disease (AD) risk, with diabetes mellitus (DM) potentially exacerbating this vulnerability. This study identifies the optimal intervention period and neurobiological targets in MCI to AD progression using the Alzheimer's Disease Neuroimaging Initiative dataset.METHODS: Analysis of 980 MCI patients, categorized by DM status, used propensity score matching and inverse probability treatment weighting to assess rate of conversion from MCI to AD, neuroimaging, and cognitive changes.RESULTS: DM significantly correlates with cognitive decline and an increased risk of progressing to AD, especially within the first year of MCI follow‐up. It adversely affects specific brain structures, notably accelerating nucleus accumbens atrophy, decreasing gray matter volume and sulcal depth.DISCUSSION: Findings suggest the first year after MCI diagnosis as the critical window for intervention. DM accelerates MCI‐to‐AD progression, targeting specific brain areas, underscoring the need for early therapeutic intervention.Highlights: Diabetes mellitus (DM) accelerates mild cognitive impairment (MCI)‐to‐Alzheimer's disease (AD) progression within the first year after MCI diagnosis. DM leads to sharper cognitive decline within 12 months of follow‐up. There is notable nucleus accumbens atrophy observed in MCI patients with DM. DM causes significant reductions in gray matter volume and sulcal depth. There are stronger correlations between cognitive decline and brain changes due to DM.Keywords
This publication has 39 references indexed in Scilit:
- Prevalence and incidence of mild cognitive impairment in adults with diabetes in the United StatesDiabetes Research and Clinical Practice, 2023
- Functional-structural decoupling in visual network is associated with cognitive decline in patients with type 2 diabetes mellitus: evidence from a multimodal MRI analysisBrain Imaging and Behavior, 2023
- Diabetes: a tipping point in neurodegenerative diseasesTrends in Molecular Medicine, 2023
- The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022Alzheimer's & Dementia, 2023
- Global rural health disparities in Alzheimer's disease and related dementias: State of the scienceAlzheimer's & Dementia, 2023
- Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairmentAlzheimer's & Dementia, 2023
- Diabetic patients treated with metformin during early stages of Alzheimer’s disease show a better integral performance: data from ADNI studyGeroScience, 2022
- Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysisSocial Psychiatry and Psychiatric Epidemiology, 2018
- Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairmentJournal of Neurology, 2018
- Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognitionBrain Structure and Function, 2013